EANM-EORTC general recommendations for sentinel node diagnostics in melanoma
Makaleler > Tam Makale · 2009
Yazarlar: Annette H. CHAKERA, Birger HESSE, Zeynep BURAK, James R. BALLINGER, Allan BRITTEN, Corrado CARACO, Alistair J. COCHRAN, Martin G. COOK, Krzysztof T. DRZEWIECKI, Richard ESSNER, Einat Even-Sapir, Alexander M. M. EGGERMONT, Tanja Gmeiner STOPAR, Christian Ingvar, Martin C. Mihm, Stanley W. McCarthy, Nicola MOZZILLO, Omgo E. NIEWEG, Richard A. Scolyer, Hans STARZ, John F. THOMPSON, Giuseppe TRIFIRO, Giuseppe VIALE, Sergi VIDAL-SICART, Roger Uren, Wendy Waddington, Arturo CHITI, Alain SPATZ, Alessandro TESTORI
European Journal of Nuclear Medicine and Molecular Imaging, SCI Expanded İndekslerine Giren Dergi, Uluslararası, Wos, 2009, cilt 36, ss 1713-1742
DOI: 10.1007/s00259-009-1228-4
Özet
The accurate diagnosis of a sentinel node in melanoma includes a sequence of procedures from different medical specialities (nuclear medicine, surgery, oncology, and pathology). The items covered are presented in 11 sections and a reference list: (1) definition of a sentinel node, (2) clinical indications, (3) radiopharmaceuticals and activity injected, (4) dosimetry, (5) injection technique, (6) image acquisition and interpretation, (7) report and display, ( 8) use of dye, ( 9) gamma probe detection, (10) surgical techniques in sentinel node biopsy, and (11) pathological evaluation of melanoma-draining sentinel lymph nodes. If specific recommendations given cannot be based on evidence from original, scientific studies, referral is given to "general consensus" and similar expressions. The recommendations are designed to assist in the practice of referral to, performance, interpretation and reporting of all steps of the sentinel node procedure in the hope of setting state-of-the-art standards for good-quality evaluation of possible spread to the lymphatic system in intermediate-to-high risk melanoma without clinical signs of dissemination.